Liver Fibrosis - Pipeline Review, H1 2013 - PowerPoint PPT Presentation

About This Presentation
Title:

Liver Fibrosis - Pipeline Review, H1 2013

Description:

Bharat Book Presents"Liver Fibrosis - Pipeline Review, H1 2013"provides an overview of the indication’s therapeutic pipeline. This report provides information on the therapeutic development for Liver Fibrosis, complete with latest updates, and special features on late-stage and discontinued projects. – PowerPoint PPT presentation

Number of Views:67
Slides: 8
Provided by: bharatbookseo
Category: Other

less

Transcript and Presenter's Notes

Title: Liver Fibrosis - Pipeline Review, H1 2013


1
Liver Fibrosis - Pipeline Review, H1 2013
  • Bharat Book Bureau

2
Summary
  • Summary'Liver Fibrosis - Pipeline Review,
    H1 2013', provides an overview of the
    indications therapeutic pipeline. This report
    provides information on the therapeutic
    development for Liver Fibrosis, complete with
    latest updates, and special features on
    late-stage and discontinued projects. It also
    reviews key players involved in the therapeutic
    development for Liver Fibrosis. Liver Fibrosis -
    Pipeline Review, Half Year is built using data
    and information sourced from Global Markets
    Directs proprietary databases,
    Company/University websites, SEC filings,
    investor presentations and featured press
    releases from company/university sites and
    industry-specific third party sources, put
    together by Global Markets Directs team.Note
    Certain sections in the report may be removed or
    altered based on the availability and relevance
    of data for the indicated disease.

3
Continue
  • Scope- A snapshot of the global
    therapeutic scenario for Liver Fibrosis.- A
    review of the Liver Fibrosis products under
    development by companies and universities/research
    institutes based on information derived from
    company and industry-specific sources.- Coverage
    of products based on various stages of
    development ranging from discovery till
    registration stages.- A feature on pipeline
    projects on the basis of monotherapy and combined
    therapeutics.- Coverage of the Liver Fibrosis
    pipeline on the basis of route of administration
    and molecule type.- Key discontinued pipeline
    projects.- Latest news and deals relating to the
    products.

4
Continue
  • Reasons to buy- Identify and understand
    important and diverse types of therapeutics under
    development for Liver Fibrosis.- Identify
    emerging players with potentially strong product
    portfolio and design effective counter-strategies
    to gain competitive advantage.- Plan mergers and
    acquisitions effectively by identifying players
    of the most promising pipeline.- Devise
    corrective measures for pipeline projects by
    understanding Liver Fibrosis pipeline depth and
    focus of Indication therapeutics.- Develop and
    design in-licensing and out-licensing strategies
    by identifying prospective partners with the most
    attractive projects to enhance and expand
    business potential and scope.- Modify the
    therapeutic portfolio by identifying discontinued
    projects and understanding the factors that drove
    them from pipeline.

5
Table of Contents
  • Table of Contents 2List of Tables 7List
    of Figures 8Introduction 9Global Markets Direct
    Report Coverage 9Liver Fibrosis Overview
    10Therapeutics Development 11An Overview of
    Pipeline Products for Liver Fibrosis 11Liver
    Fibrosis Therapeutics under Development by
    Companies 13Liver Fibrosis Therapeutics under
    Investigation by Universities/Institutes 16Late
    Stage Products 17Comparative Analysis 17Mid
    Clinical Stage Products 18Comparative Analysis
    18Early Clinical Stage Products 19
  • Comparative Analysis 19Discovery and
    Pre-Clinical Stage Products 20Comparative
    Analysis 20

6
Continue
  • Liver Fibrosis Therapeutics Products
    under Development by Companies 21Liver Fibrosis
    Therapeutics Products under Investigation by
    Universities/Institutes 24Companies Involved in
    Liver Fibrosis Therapeutics Development
    25Bristol-Myers Squibb Company 25Genzyme
    Corporation 26Gilead Sciences, Inc. 27Bioneer
    Corporation 28ViaCord 29FibroGen, Inc.
    30Silence Therapeutics plc. 31Genfit 32La
    Jolla Pharmaceutical Company 33LG Life
    Sciences,  Ltd 34Digna Biotech, S.L.
    35GenKyoTex S.A. 36

7
For More Information You Can Visit-
  • http//www.bharatbook.com/market-research-rep
    orts/healthcare-market-research-report/liver-fibro
    sis-pipeline-review-h1-2013.html Or visit us
    at
  • Bharat
    Book Bureau
  • Phone
    91 22 27810772, 27810773
  • Toll Free
    No for USA/Canada 1-866-279-8368
  • E-mail
    info_at_bharatbook.com
  • Website
    www.bharatbook.com
  • Twitter
    https//twitter.com/BharatBook
  • Blog
    http//www.bharatbook.com/market-reports-blog/
Write a Comment
User Comments (0)
About PowerShow.com